Projections of anxiety disorder prevalence during and beyond the COVID-19 pandemic in Germany using the illness-death model.

BJPsych Open

Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany; and Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.

Published: October 2024

AI Article Synopsis

  • The study investigates the long-term effects of the COVID-19 pandemic on anxiety disorders in Germany, projecting prevalence rates up to 2030 for both men and women.* -
  • Using a three-state illness-death model and historical data, the researchers estimate that without additional pandemic-related increases, approximately 3.86 million women and 2.13 million men will have anxiety disorders by 2030; with potential increases, those numbers could rise to 5.67 million women and 3.30 million men.* -
  • The findings suggest that any rise in anxiety cases during the pandemic has lasting implications, highlighting the need for effective public health planning as more data becomes available.*

Article Abstract

Background: Although there is now substantial evidence on the acute impacts of the COVID-19 pandemic on anxiety disorders, the long-term population impact of the pandemic remains largely unexplored.

Aims: To quantify a possible longitudinal population-level impact of the pandemic by projecting the prevalence of anxiety disorders through 2030 among men and women aged up to 95 years in Germany under scenarios with varying impacts of the pandemic on the incidence of anxiety disorders.

Method: We used a three-state illness-death model and data from the Global Burden of Disease Study to model historical trends of the prevalence and incidence of anxiety disorders. The German population projections determined the initial values for projections. The COVID-19 incidence rate data informed an additional incidence model, which was parameterised with a wash-in period, delay, wash-out period, incidence increase level and decay constant.

Results: When no additional increase in the incidence during the pandemic waves during 2020-2022 was assumed, it was estimated that 3.86 million women (9.96%) and 2.13 million men (5.40%) would have anxiety disorders in 2030. When increases in incidence following pandemic waves were assumed, the most extreme scenario projected 5.67 million (14.02%) women and 3.30 million (8.14%) men with the mental disorder in 2030.

Conclusions: Any increased incidence during the pandemic resulted in elevated prevalence over the projection period. Projection of anxiety disorder prevalence based on the illness-death model enables simulations with varying assumptions and provides insight for public health planning. These findings should be refined as trend data accumulate and become available.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536217PMC
http://dx.doi.org/10.1192/bjo.2024.754DOI Listing

Publication Analysis

Top Keywords

anxiety disorders
16
illness-death model
12
incidence pandemic
12
anxiety disorder
8
disorder prevalence
8
pandemic
8
covid-19 pandemic
8
impact pandemic
8
disorders 2030
8
incidence
8

Similar Publications

The COVID-19 outbreak, caused by the SARS-CoV-2 virus, was linked to significant neurological and psychiatric manifestations. This review examines the physiopathological mechanisms underlying these neuropsychiatric outcomes and discusses current management strategies. Primarily a respiratory disease, COVID-19 frequently leads to neurological issues, including cephalalgia and migraines, loss of sensory perception, cerebrovascular accidents, and neurological impairment such as encephalopathy.

View Article and Find Full Text PDF

: Avoidance of ultra-processed foods (UPFs) has been recommended to achieve a healthy diet, but whether it applies equally to all UPFs is uncertain. We evaluated individual UPF subgroups in the prediction of cardiometabolic and mental health outcomes. : The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is an occupational cohort study of 15,105 adults (35-74 years) recruited in 2008-2010.

View Article and Find Full Text PDF

: Sleep, a process physiologically vital for mental health, faces disruptions in various sleep disorders linked to metabolic and neurodegenerative risks. seed (Zizy) has long been recognized for its diverse pharmacological attributes, including analgesic, sedative, insomnia, and anxiety alleviation. : In this study, the sleep-prolonging effects of Zizy extract (100, 200 mg/kg), along with their characterizing compounds jujuboside A (JuA) (5, 10 mg/kg), were evaluated in a mouse model under a pentobarbital-induced sleep.

View Article and Find Full Text PDF

Medicinal Cannabis and the Intestinal Microbiome.

Pharmaceuticals (Basel)

December 2024

Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

Historically, the multiple uses of cannabis as a medicine, food, and for recreational purposes as a psychoactive drug span several centuries. The various components of the plant (i.e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!